African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression

Jacqueline Jones, Angana Mukherjee, Balasubramanyam Karanam, Melissa B Davis, Jesse Jaynes, R. Renee Reams, Windy Dean-Colomb, Clayton Yates

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Kaiso, a bi-modal transcription factor, regulates gene expression, and is elevated in breast, prostate, and colon cancers. Depletion of Kaiso in other cancer types leads to a reduction in markers for the epithelial–mesenchymal transition (EMT) (Jones et al., 2014), however its clinical implications in pancreatic ductal adenocarcinoma (PDCA) have not been widely explored. PDCA is rarely detected at an early stage but is characterized by rapid progression and invasiveness. We now report the significance of the subcellular localization of Kaiso in PDCAs from African Americans. Kaiso expression is higher in the cytoplasm of invasive and metastatic pancreatic cancers. In males, cytoplasmic expression of Kaiso correlates with cancer grade and lymph node positivity. In male and female patients, cytoplasmic Kaiso expression correlates with invasiveness. Also, nuclear expression of Kaiso increases with increased invasiveness and lymph node positivity. Further, analysis of the largest PDCA dataset available on ONCOMINE shows that as Kaiso increases, there is an overall increase in Zeb1, which is the inverse for E-cadherin. Hence, these findings suggest a role for Kaiso in the progression of PDCAs, involving the EMT markers, E-cadherin and Zeb1.

Original languageEnglish (US)
Pages (from-to)513-522
Number of pages10
JournalCancer Letters
Volume380
Issue number2
DOIs
StatePublished - Oct 1 2016
Externally publishedYes

Fingerprint

African Americans
Adenocarcinoma
Cadherins
Lymph Nodes
Pancreatic Neoplasms
Colonic Neoplasms
Neoplasms
Prostatic Neoplasms
Cytoplasm
Transcription Factors
Breast Neoplasms
Gene Expression
Datasets

Keywords

  • EMT markers
  • Kaiso
  • Pancreatic ductal carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Jones, J., Mukherjee, A., Karanam, B., Davis, M. B., Jaynes, J., Reams, R. R., ... Yates, C. (2016). African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Letters, 380(2), 513-522. https://doi.org/10.1016/j.canlet.2016.06.025

African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. / Jones, Jacqueline; Mukherjee, Angana; Karanam, Balasubramanyam; Davis, Melissa B; Jaynes, Jesse; Reams, R. Renee; Dean-Colomb, Windy; Yates, Clayton.

In: Cancer Letters, Vol. 380, No. 2, 01.10.2016, p. 513-522.

Research output: Contribution to journalArticle

Jones, J, Mukherjee, A, Karanam, B, Davis, MB, Jaynes, J, Reams, RR, Dean-Colomb, W & Yates, C 2016, 'African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression', Cancer Letters, vol. 380, no. 2, pp. 513-522. https://doi.org/10.1016/j.canlet.2016.06.025
Jones, Jacqueline ; Mukherjee, Angana ; Karanam, Balasubramanyam ; Davis, Melissa B ; Jaynes, Jesse ; Reams, R. Renee ; Dean-Colomb, Windy ; Yates, Clayton. / African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. In: Cancer Letters. 2016 ; Vol. 380, No. 2. pp. 513-522.
@article{6bccb348c75e4c7eb5593f3016afa268,
title = "African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression",
abstract = "Kaiso, a bi-modal transcription factor, regulates gene expression, and is elevated in breast, prostate, and colon cancers. Depletion of Kaiso in other cancer types leads to a reduction in markers for the epithelial–mesenchymal transition (EMT) (Jones et al., 2014), however its clinical implications in pancreatic ductal adenocarcinoma (PDCA) have not been widely explored. PDCA is rarely detected at an early stage but is characterized by rapid progression and invasiveness. We now report the significance of the subcellular localization of Kaiso in PDCAs from African Americans. Kaiso expression is higher in the cytoplasm of invasive and metastatic pancreatic cancers. In males, cytoplasmic expression of Kaiso correlates with cancer grade and lymph node positivity. In male and female patients, cytoplasmic Kaiso expression correlates with invasiveness. Also, nuclear expression of Kaiso increases with increased invasiveness and lymph node positivity. Further, analysis of the largest PDCA dataset available on ONCOMINE shows that as Kaiso increases, there is an overall increase in Zeb1, which is the inverse for E-cadherin. Hence, these findings suggest a role for Kaiso in the progression of PDCAs, involving the EMT markers, E-cadherin and Zeb1.",
keywords = "EMT markers, Kaiso, Pancreatic ductal carcinoma",
author = "Jacqueline Jones and Angana Mukherjee and Balasubramanyam Karanam and Davis, {Melissa B} and Jesse Jaynes and Reams, {R. Renee} and Windy Dean-Colomb and Clayton Yates",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.canlet.2016.06.025",
language = "English (US)",
volume = "380",
pages = "513--522",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression

AU - Jones, Jacqueline

AU - Mukherjee, Angana

AU - Karanam, Balasubramanyam

AU - Davis, Melissa B

AU - Jaynes, Jesse

AU - Reams, R. Renee

AU - Dean-Colomb, Windy

AU - Yates, Clayton

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Kaiso, a bi-modal transcription factor, regulates gene expression, and is elevated in breast, prostate, and colon cancers. Depletion of Kaiso in other cancer types leads to a reduction in markers for the epithelial–mesenchymal transition (EMT) (Jones et al., 2014), however its clinical implications in pancreatic ductal adenocarcinoma (PDCA) have not been widely explored. PDCA is rarely detected at an early stage but is characterized by rapid progression and invasiveness. We now report the significance of the subcellular localization of Kaiso in PDCAs from African Americans. Kaiso expression is higher in the cytoplasm of invasive and metastatic pancreatic cancers. In males, cytoplasmic expression of Kaiso correlates with cancer grade and lymph node positivity. In male and female patients, cytoplasmic Kaiso expression correlates with invasiveness. Also, nuclear expression of Kaiso increases with increased invasiveness and lymph node positivity. Further, analysis of the largest PDCA dataset available on ONCOMINE shows that as Kaiso increases, there is an overall increase in Zeb1, which is the inverse for E-cadherin. Hence, these findings suggest a role for Kaiso in the progression of PDCAs, involving the EMT markers, E-cadherin and Zeb1.

AB - Kaiso, a bi-modal transcription factor, regulates gene expression, and is elevated in breast, prostate, and colon cancers. Depletion of Kaiso in other cancer types leads to a reduction in markers for the epithelial–mesenchymal transition (EMT) (Jones et al., 2014), however its clinical implications in pancreatic ductal adenocarcinoma (PDCA) have not been widely explored. PDCA is rarely detected at an early stage but is characterized by rapid progression and invasiveness. We now report the significance of the subcellular localization of Kaiso in PDCAs from African Americans. Kaiso expression is higher in the cytoplasm of invasive and metastatic pancreatic cancers. In males, cytoplasmic expression of Kaiso correlates with cancer grade and lymph node positivity. In male and female patients, cytoplasmic Kaiso expression correlates with invasiveness. Also, nuclear expression of Kaiso increases with increased invasiveness and lymph node positivity. Further, analysis of the largest PDCA dataset available on ONCOMINE shows that as Kaiso increases, there is an overall increase in Zeb1, which is the inverse for E-cadherin. Hence, these findings suggest a role for Kaiso in the progression of PDCAs, involving the EMT markers, E-cadherin and Zeb1.

KW - EMT markers

KW - Kaiso

KW - Pancreatic ductal carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84981172782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981172782&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2016.06.025

DO - 10.1016/j.canlet.2016.06.025

M3 - Article

C2 - 27424525

AN - SCOPUS:84981172782

VL - 380

SP - 513

EP - 522

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -